TACLONEX

LEO Pharma Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 30, 2017
Approval ID: 757c914f-dd8d-43cc-a973-212d591af4af
Products: 1 registered
Version: 25

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TACLONEX Topical Suspension safely and effectively. See full prescribing information for TACLONEX Topical Suspension. TACLONEX (calcipotriene and betamethasone dipropionate) topical suspension Initial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.